Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The study plans to determine the relationship between plasma concentrations of 17-OHPC hydroxyprogesterone caproate (17-OHPC) and the rate of preterm birth. The study is an open label study of pregnant women with one or more prior spontaneous preterm births who are receiving either 250mg of 500 mg of 17-OHPC as a weekly single injection. The safety of the 500 mg dose will also be assessed.
Epistemonikos ID: de0eab856bb8180ad523fa4b7e81c45d8ead1651
First added on: May 21, 2024